Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce

4.8/5 on G2· Since 2015

Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Jul 01, 2024

Contract Type

partnership

Pembroke PinesManufacturingBiotechnologyHealthcareHealth Care

Description

Merck and Orion announced the mutual exercise of an option to convert their ongoing co-development and co-commercialization agreement for opevesostat, an investigational CYP11A1 inhibitor, into an exclusive global license for Merck. This will allow Merck to advance the clinical development program for opevesostat and address the needs of patients living with prostate cancer.

Company Information

Company

Merck

Location

19700 STIRLING ROAD

Pembroke Pines, Florida, United States

About

For over 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.